High fitness level may decrease risk of colorectal, lung cancers

the ONA take:

According to a new study published online in JAMA Oncology, researchers from the University of Vermont in Burlington, Vermont, have found that men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.

For the study, researchers identified 13,949 men who had a baseline fitness exam where cardiorespiratory fitness (CRF) was assessed and had Medicare data of lung, prostate, and colorectal cancer diagnoses. Results showed that during a mean follow-up of 6.5 years, 1,310 were diagnosed with prostate cancer, 200 with lung cancer, and 181 with colorectal cancer.

The researchers found that those who had a high CRF during midlife had a 55% decreased risk of lung cancer and a 44% decreased risk of colorectal cancer compared with men with low CRF. Those with high CRF did not have a decreased risk for prostate cancer.

Researchers also found that men with high CRF in midline had a 32% decreased risk of cancer death among those who were diagnosed with colorectal, lung, or prostate cancer when they were older compared with men with low CRF.

Men with high CRF in midlife had a 68% decreased risk of cardiovascular disease-associated death compared with men with low CRF who developed cancer.

High fitness level may decrease risk of colorectal, lung cancers
Men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.
Men with a high fitness level in midlife appear to be at lower risk for lung and colorectal cancer, but not prostate cancer, according to a study published online by JAMA Oncology.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs